Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 140 are a BUY (89.74%), 15 are a HOLD (9.62%), 1 are a SELL (0.64%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 50.09% that have a potential upside of 35.63% achieved within 182 days.
Bruce Jackson’s has documented 282 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLNN, Clene at 10-Sep-2025.
Analyst best performing recommendations are on GNLX (GENELUX COMMON STOCK).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/16/2021. The price target of $220 was fulfilled within 5 days with a profit of $82 (59.42%) receiving and performance score of 118.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$7.5
4 years 3 months ago
(21-Jul-2021)
2/2 (100%)
$2.76 (58.23%)
256
Hold
$10
$9.54 (2073.91%)
$8
4 years 10 months 19 days ago
(02-Dec-2020)
0/3 (0%)
$2.49 (33.16%)
Buy
5 years 4 months 5 days ago
(16-Jun-2020)
2/2 (100%)
$1.27 (34.05%)
162
Buy
$12
$11.54 (2508.70%)
5 years 6 months 6 days ago
(15-Apr-2020)
2/2 (100%)
$-0.66 (-5.21%)
83
Which stock is Bruce Jackson is most bullish on?
Which stock is Bruce Jackson is most reserved on?
What Year was the first public recommendation made by Bruce Jackson?